Topic

Aetna (CVS Health)

A collection of 1351 issues

How to Get Evrysdi (Risdiplam) Covered by Aetna CVS Health in Georgia: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Evrysdi Covered by Aetna CVS Health in Georgia Evrysdi (risdiplam) is covered by Aetna CVS Health in Georgia but requires prior authorization for all plan types. Your fastest path to approval: (1) Have your neurologist submit genetic testing results showing biallelic SMN1 mutations, (2) Include baseline motor

How to Get Enhertu Covered by Aetna CVS Health in Pennsylvania: Complete Prior Authorization Guide with Appeals Process

Answer Box: Getting Enhertu Covered by Aetna CVS Health in Pennsylvania Enhertu (fam-trastuzumab deruxtecan-nxki) requires prior authorization from Aetna CVS Health for all FDA-approved cancer indications. Your oncologist must submit documentation proving HER2-positive, HER2-low, or HER2-mutant status plus evidence of prior therapy failures. The fastest path: gather HER2 testing results

Renewing Rapivab (Peramivir) Approval with Aetna CVS Health in New York: Complete Guide to Forms, Timelines, and Appeals

Answer Box: Renewing Rapivab (Peramivir) with Aetna CVS Health in New York Rapivab requires prior authorization (PA) renewal from Aetna CVS Health for continued coverage, typically requiring updated clinical documentation within 48 hours of symptom onset and proof of contraindications to oral antivirals. Start renewal 2-3 weeks before current approval

How to Get Bavencio (Avelumab) Covered by Aetna CVS Health in Pennsylvania: Prior Authorization Guide, ICD-10 Codes, and Appeals Process

Answer Box: Getting Bavencio Covered by Aetna CVS Health in Pennsylvania Aetna CVS Health requires prior authorization for Bavencio (avelumab) in Pennsylvania. The fastest path to approval: 1) Verify your oncologist submits the PA request with confirmed ICD-10 diagnosis codes (C4A for Merkel cell carcinoma, C67 for urothelial carcinoma) and

How to Get Kymriah (tisagenlecleucel) Covered by Aetna CVS Health in Pennsylvania: Complete Guide to Approval, Appeals, and Renewal

Answer Box: Getting Kymriah Covered by Aetna CVS Health in Pennsylvania Kymriah (tisagenlecleucel) requires prior authorization from Aetna CVS Health. Start by having your oncologist submit a Letter of Medical Necessity documenting your CD19+ B-cell ALL or DLBCL, prior therapy failures, and treatment at a FACT-accredited center. If denied, you

Aetna (CVS Health)'s Coverage Criteria for Cystadane (betaine anhydrous) in Washington: What Counts as "Medically Necessary"?

Answer Box: Getting Cystadane (betaine anhydrous) Covered by Aetna (CVS Health) in Washington Aetna (CVS Health) covers Cystadane (betaine anhydrous) for homocystinuria with prior authorization and specialty pharmacy requirements. The fastest path to approval requires: (1) confirmed genetic or biochemical diagnosis of homocystinuria due to CBS, MTHFR, or cobalamin defects,

Do You Qualify for Elzonris (tagraxofusp-erzs) Coverage by Aetna (CVS Health) in Virginia? Decision Tree & Next Steps

Answer Box: Your Path to Elzonris Coverage Quick eligibility check: You likely qualify for Elzonris (tagraxofusp-erzs) coverage through Aetna (CVS Health) in Virginia if you have confirmed CD123-positive BPDCN and meet safety monitoring requirements. First step today: Have your hematologist/oncologist submit a prior authorization request with pathology reports showing

Renewing Jynarque (Tolvaptan) Approval with Aetna CVS Health in Pennsylvania: Complete Guide with Timelines and Requirements

Answer Box: Renewing Your Jynarque (Tolvaptan) Approval Start your renewal 30-60 days before your current PA expires. You'll need recent liver function tests (within 3 months), eGFR trends showing benefit, and REMS compliance documentation. Submit through your nephrologist via Aetna's Specialty Medication Request Form. Typical decision

How to Get Vyondys 53 (Golodirsen) Covered by Aetna CVS Health in Washington: Complete Prior Authorization & Appeals Guide

Answer Box: Quick Path to Vyondys 53 Coverage Getting Vyondys 53 approved by Aetna CVS Health in Washington requires: (1) genetic testing proving exon 53-amenable DMD mutation from CLIA-certified lab, (2) neuromuscular specialist prescription with baseline 6-minute walk test ≥250 meters, (3) completed Aetna Vyondys 53 precertification form with monitoring

How to Get Strimvelis Gene Therapy Covered by Aetna CVS Health in Michigan: Complete Coding, Appeals & Authorization Guide

Answer Box: Getting Strimvelis Covered by Aetna CVS Health in Michigan Strimvelis (autologous CD34+ gene therapy for ADA-SCID) requires prior authorization from Aetna CVS Health in Michigan. Use ICD-10 code D81.31 and HCPCS J3590 for billing. Submit genetic confirmation, enzyme testing showing <1% ADA activity, and proof of